VENUS REMEDIES LTD
Venus Remedies has declared its results
for the third Quarter ends December, 2012.
The results are analyzed below :
Net Sales for the 3rd
Quarter stands at Rs.111.62 Cr; compared to Rs.110.66 cr in the Q2 FY 13 (+0.87%); and Rs.94.1Cr in Q3 FY 12 (+18.62%).
Total Income for the 3rd
Qtr stands at Rs.112.64 Cr compared to Rs.110.81 Cr in Q2 FY 12 (+ 1.65%); and
Rs.95.83 Cr in Q3 FY 12 (+ 17.54%). The improvement in Net Sales and total
income on YoY basis is very good.
Total Expenses for the 3rd Qtr stands
at Rs.90.74 Cr compared to Rs.90 Cr in
Q2 FY 12 (+ 0.82%); and Rs.78.21 Cr in Q3 FY 12 (+16.02%). The rise in expenses
is lower, compared to Income.
Operating Profit for the 3rd
Qtr stands at Rs.21.89 Cr compared to Rs.20.81 Cr in Q2 FY 12 (+ 5.19%); and
Rs.17.62 Cr in Q3 FY 12 (+24.23%). Operating Profit has gone up impressively
Finance Costs for the 3rd Qtr stands at
Rs.5.29 Cr compared to Rs.5.37 Cr in Q2 FY 12 (-1.49%); and Rs.6.68 Cr in Q3
FY 12 (-20.81%).
Tax Expense for
the 3rd Qtr stands at Rs.0.9 Cr;
compared to Rs.0.6 Cr in Q2 FY 12 (+ 50%); and Rs.0.7 Cr in Q3 FY
12 (+28.57%).
Net Profit for the 3rd
Qtr stands at Rs.16.06 Cr; compared to
Rs.15.09 Cr in Q2 FY 12 (+ 6.43%) and Rs.10.33 Cr in Q3 FY 12 ( +55.47%).Net
Profit YoY has jumped impressively due to higher sales (+18.62%) and
proportionately lower total expenses (+16.02%) and lower fiancé costs
(-20.81%).
Equity stands at Rs.9.742
EPS for the 3rd Qtr
stands at Rs.16.48 compared to Rs.15.49 in
Q2 FY 13; and Rs.10.33 in Q3 FY 12.
EPS-Annualised for the 3rd Qtr stands at Rs.65.92
compared to Rs.61.97 in the second Qtr
and Rs.45.21 in Q3 FY 12.
9 MONTHE ENDED
DEC,2012
Net Sales for the 9 m/e Dec,2012
stands at Rs.334.9 Cr; compared to Rs.289.1 cr (+15.84%); while the same for
the full Year ended March 2012 stands at Rs.402.39 Cr.
Total Income for
the 9 m/e Dec,2012 stands at Rs.336.02 Cr; compared to Rs.290.95 cr (+15.49%);
while the same for the full Year ended March 2012 stands at Rs. 405.19 Cr.
Total Expenses for the 9 m/e Dec,2012 stands at
Rs.271.4 Cr; compared to Rs.232.6 cr (+16.68%); while the same for the full
Year ended March 2012 stands at Rs.323.15 Cr.
Operating Profit for the 9 m/e Dec,2012
stands at Rs.64.66 Cr; compared to Rs.58.32 cr (+10.87%); while the same for
the full Year ended March 2012 stands at Rs.82.04 Cr.
Finance Costs for
the 9 m/e Dec,2012 stands at Rs.18.28 Cr; compared to Rs.18.64 cr (-1.93%);
while the same for the full Year ended March 2012 stands at Rs.27.26 Cr.
Tax Expense for
the 9 m/e Dec,2012 stands at Rs.1.9 Cr;
compared to Rs.4.15 cr (-54.22%); while the same for the full Year ended March
2012 stands at Rs.5.12 Cr.
Net Profit for the 9 m/e Dec,2012 stands at
Rs.45.19 Cr; compared to Rs.35.71 cr (+26.55%); while the same for the full
Year ended March 2012 stands at Rs.50.03 Cr. The jump on YoY basis is quite
good.
EPS for the 9 m/e Dec,2012 stands at Rs.45.19;
compared to Rs.35.71 (+26.55%); while
the same for the full Year ended March 2012 stands at Rs.50.03 .
EPS-Annualised for the 9 m/e Dec,2012 stands at
Rs.61.85; compared to Rs.52.08 (+18.76%); while the same for the full Year
ended March 2012 stands at Rs.51.35.
The performance of the company for the third quarter and for the 9 months ending Dec,2012 is quite impressive. It has been improving its performance steadily every quarter. The stock price has jumped almost Rs.30.50 on declaration of results - to Rs.277.95. Even at this price, its PE Ratio is hardly 4.1 - leaving huge scope for appreciation.
* * * E N D * * *
No comments:
Post a Comment